Literature DB >> 7842740

Physical mapping of 3 candidate tumor suppressor genes relative to Beckwith-Wiedemann syndrome associated chromosomal breakpoints at 11p15.3.

E Redeker1, M Alders, J M Hoovers, C W Richard, A Westerveld, M Mannens.   

Abstract

A physical map encompassing the 3 Mb region containing the breakpoints of two Beckwith-Wiedemann Syndrome patients at chromosome band 11p15.3 is presented. The candidate tumor suppressor genes WEE1, ST5, and rhombotin, are positioned on this map relative to these Beckwith-Wiedemann syndrome translocation and inversion breakpoints.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7842740     DOI: 10.1159/000133917

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  5 in total

Review 1.  Beckwith-Wiedemann syndrome: imprinting in clusters revisited.

Authors:  E R Maher; W Reik
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Acid sphingomyelinase deficiency in Beckwith Wiedemann syndrome.

Authors:  L A Réthy ; R Kálmánchey ; V Klujber ; R Koós ; G Fekete
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Disruption of a novel imprinted zinc-finger gene, ZNF215, in Beckwith-Wiedemann syndrome.

Authors:  M Alders; A Ryan; M Hodges; J Bliek; A P Feinberg; O Privitera; A Westerveld; P F Little; M Mannens
Journal:  Am J Hum Genet       Date:  2000-04-10       Impact factor: 11.025

4.  Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast.

Authors:  J H Lichy; M Zavar; M M Tsai; T J O'Leary; J K Taubenberger
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

5.  The serine/threonine kinase 33 is present and expressed in palaeognath birds but has become a unitary pseudogene in neognaths about 100 million years ago.

Authors:  Tobias Lautwein; Steffen Lerch; Daniel Schäfer; Erwin R Schmidt
Journal:  BMC Genomics       Date:  2015-07-22       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.